Update on leucocyte depletion of blood components by filtration.
It has long been recognized that allogenic leucocytes from donor blood are responsible for serious untoward effects in some transfused patients such as alloimmunization, febrile reactions, platelet refractoriness, transfusion associated acute lung injury, immunosuppression as well as transmission or reactivation of viruses such as CMV, HTLV or EBV. Leucocytes are also known to accelerate the rate of storage lesion. The optimal method to remove leucocytes from blood components has been shown to be filtration. However, many variables exist in the properties of leuco-depletion filters (material, composition, surface charge, mechanisms of leucocyte entrapment), the blood components to be filtered (composition, age), and the filtration method (pre- or post-storage, priming and rinsing, temperature, flow rate). In this paper principles of filtration and subsequent logistic consequences will be discussed. It is recommended to carefully select a filter for a specific blood component and to perform leuco-depletion procedures under controlled conditions according to validated methods meeting Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP).
Pietersz
R N
RN
Red Cross Blood Bank, Amsterdam, The Netherlands.
van der Meer
P F
PF
Seghatchian
M J
MJ
D016913:Blood Component Transfusion / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D001793:Blood Preservation; D002448:Cell Adhesion; D002469:Cell Separation / Q000295:instrumentation / Q000379:methods*; D005334:Fever / Q000517:prevention & control; D005374:Filtration / Q000295:instrumentation / Q000379:methods; D006087:Graft vs Host Reaction; D006801:Humans; D007962:Leukocytes / Q000276:immunology / Q000821:virology; D011786:Quality Control; D012449:Safety; D013696:Temperature; D013997:Time Factors; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission